This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Cramer-van der Welle CM, et al. Trends in Drug Costs and Overall Survival in Patients with Metastatic Non-small Cell Lung Cancer in The Netherlands Diagnosed from 2008 Through 2014. PharmacoEconomics-Open : 12 Jun 2020. Available from: URL: https://doi.org/10.1007/s41669-020-00220-z
About this article
Cite this article
Drug costs for metastatic NSCLC stable, overall survival benefit poor. PharmacoEcon Outcomes News 856, 14 (2020). https://doi.org/10.1007/s40274-020-6914-2